Miniature Surgical Implants for Glaucoma Patients
Optonol's flagship product, Ex-Press, is a miniature surgical implant used to lower intra-ocular pressure in patients with glaucoma. Optonol was founded as a spin-off of Jerusalem-based stent developer Medinol Ltd. Optonol was acquired by Alcon in December 2009. A year later, Alcon was acquired by Novartis.
| Name | Optonol |
|---|---|
| Slug | optonol |
| Type / kind | startup |
| Crunchbase ID | optonol |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoKThkIcKDA |
| Status | acquired |
|---|---|
| Status reason | Acquired by Alcon on Dec, 2009 |
| Last update | 2026-05-17 |
| HQ country code | IL |
|---|---|
| HQ region/district | Jerusalem District |
| HQ city | Neve Ilan |
| HQ address | Neve Ilan, Israel |
| Website | http://optonol.com |
|---|---|
| https://www.linkedin.com/company/146920 |
| Total raised | $30.0M |
|---|---|
| Current stage | Acquired |
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}